Program News
News and stories about members of the UNC Lineberger Cancer Genetics Research Program
-
Scientific symposium highlights latest developments in pancreatic cancer research
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.
-
Cancer center researchers to present latest findings at international breast cancer meeting
The San Antonio Breast Cancer Symposium features presentations outlining basic, translational, clinical and community-based study findings focused on advancing the prevention, diagnosis and treatment of breast cancer.
-
Scientists piece together DNA repair pathway implicated in breast, ovarian, and prostate cancers
Researchers have learned more about an enzyme found to be overly expressed in patients with hereditary breast cancer, ovarian cancer and prostate cancer.
-
UNC Lineberger faculty named world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.
-
Perou elected as fellow of the American Association for Cancer Research Academy
The AACR has elected Charles Perou, PhD, as a fellow to the AACR Academy. Members of this year’s class will be formally recognized at the AACR’s annual meeting.
-
American Association for Cancer Research’s annual meeting to feature UNC Lineberger experts, research
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
-
Office of Graduate Education recognizes four Lineberger members with mentorship awards
The UNC School of Medicine Office of Graduate Education presented mentorship awards to four UNC Lineberger members, Jessica Bowser, PhD, Sharon Campbell, PhD, Charles Perou, PhD, and Will Valdar, PhD.
-
Ian Davis awarded $1 million by V Foundation
UNC Lineberger’s Ian Davis, MD, PhD, was awarded $1 million by the The V Foundation to support his work to improve CAR-T therapy for pediatric solid tumors.
-
Study identifies molecular differences between primary breast cancer and its metastases
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.
-
Immune system B-cells can help predict HER2-positive breast cancer treatment response
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
-
Perou presents AACR Distinguished Lectureship in Breast Cancer Research
Charles Perou, PhD, presented the 2022 AACR Distinguished Lectureship in Breast Cancer Research at the 45th San Antonio Breast Cancer Symposium.
-
UNC Lineberger faculty recognized as world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
-
Genetic analysis of the most common type of bladder cancer in patients with metastatic disease yields guidance on treatment options
A genomic study of more than 200 people with the most common type of bladder cancer that has spread could help guide how the cancer would respond to immunotherapy.
-
Scientists discover surprise anticancer properties of common lab molecule
Aziz Sancar, MD, PhD, and colleagues report that a common molecular tool for DNA labeling also has anticancer properties worthy of further investigation, especially for brain cancers.
-
UNC Lineberger creates RNA Discovery Center
The UNC RNA Discovery Center, led by Chad Pecot, MD, will cultivate an inclusive community of scientists dedicated to investigating all aspects of RNA biology.